A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group

The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known a...

Full description

Saved in:
Bibliographic Details
Published inThe oncologist (Dayton, Ohio) Vol. 25; no. 6; pp. e936 - e945
Main Authors Al‐Shamsi, Humaid O., Alhazzani, Waleed, Alhuraiji, Ahmad, Coomes, Eric A., Chemaly, Roy F., Almuhanna, Meshari, Wolff, Robert A., Ibrahim, Nuhad K., Chua, Melvin L.K., Hotte, Sebastien J., Meyers, Brandon M., Elfiki, Tarek, Curigliano, Giuseppe, Eng, Cathy, Grothey, Axel, Xie, Conghua
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2020
Subjects
Betacoronavirus - isolation & purification
Betacoronavirus - pathogenicity
Coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
Coronavirus Infections - virology
COVID-19
Global Health and Cancer
Hand Hygiene - organization & administration
Hand Hygiene - trends
Humans
Infection Control - organization & administration
Infection Control - trends
Influenza
International Cooperation
Intersectoral Collaboration
Medical Oncology - economics
Medical Oncology - organization & administration
Medical Oncology - standards
Medical Oncology - trends
Neoplasm
Neoplasms - therapy
Pandemic
Pandemics - prevention & control
Patient Care - economics
Patient Care - standards
Patient Care - trends
Patient Education as Topic
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
Pneumonia, Viral - virology
Resource Allocation - economics
Resource Allocation - organization & administration
Resource Allocation - standards
Resource Allocation - trends
SARS-CoV-2
Telemedicine - economics
Telemedicine - organization & administration
Telemedicine - standards
Telemedicine - trends
World Health Organization
COVID-19
Neoplasm
Pandemic
SARS-CoV-2
Coronavirus
Influenza
Online AccessGet full text

Cover

Abstract The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID‐19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is characterized by rapid human‐to‐human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS‐CoV‐2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID‐19 infection pandemic will be addressed, with suggestions of some practical approaches. Implications for Practice The main management strategies for treating cancer patients during the COVID‐19 epidemic include clear communication and education about hand hygiene, infection control measures, high‐risk exposure, and the signs and symptoms of COVID‐19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case‐by‐case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS‐CoV‐2 virology and epidemiology. Cancer patients have an increased risk of contracting COVID‐19. This article addresses the challenges associated with managing cancer patients during the COVID‐19 infection pandemic and suggests some practical approaches.
AbstractList The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. IMPLICATIONS FOR PRACTICE: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. IMPLICATIONS FOR PRACTICE: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.
Cancer patients have an increased risk of contracting COVID‐19. This article addresses the challenges associated with managing cancer patients during the COVID‐19 infection pandemic and suggests some practical approaches.
The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID‐19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), is characterized by rapid human‐to‐human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS‐CoV‐2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID‐19 infection pandemic will be addressed, with suggestions of some practical approaches. Implications for Practice The main management strategies for treating cancer patients during the COVID‐19 epidemic include clear communication and education about hand hygiene, infection control measures, high‐risk exposure, and the signs and symptoms of COVID‐19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case‐by‐case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS‐CoV‐2 virology and epidemiology. Cancer patients have an increased risk of contracting COVID‐19. This article addresses the challenges associated with managing cancer patients during the COVID‐19 infection pandemic and suggests some practical approaches.
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international concern and has now been declared a pandemic by the World Health Organization (WHO). In December 2019, an outbreak of atypical pneumonia, known as COVID-19, was identified in Wuhan, China. The newly identified zoonotic coronavirus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by rapid human-to-human transmission. Many cancer patients frequently visit the hospital for treatment and disease surveillance. They may be immunocompromised due to the underlying malignancy or anticancer therapy and are at higher risk of developing infections. Several factors increase the risk of infection, and cancer patients commonly have multiple risk factors. Cancer patients appear to have an estimated twofold increased risk of contracting SARS-CoV-2 than the general population. With the WHO declaring the novel coronavirus outbreak a pandemic, there is an urgent need to address the impact of such a pandemic on cancer patients. This include changes to resource allocation, clinical care, and the consent process during a pandemic. Currently and due to limited data, there are no international guidelines to address the management of cancer patients in any infectious pandemic. In this review, the potential challenges associated with managing cancer patients during the COVID-19 infection pandemic will be addressed, with suggestions of some practical approaches. IMPLICATIONS FOR PRACTICE: The main management strategies for treating cancer patients during the COVID-19 epidemic include clear communication and education about hand hygiene, infection control measures, high-risk exposure, and the signs and symptoms of COVID-19. Consideration of risk and benefit for active intervention in the cancer population must be individualized. Postponing elective surgery or adjuvant chemotherapy for cancer patients with low risk of progression should be considered on a case-by-case basis. Minimizing outpatient visits can help to mitigate exposure and possible further transmission. Telemedicine may be used to support patients to minimize number of visits and risk of exposure. More research is needed to better understand SARS-CoV-2 virology and epidemiology.
Author Chua, Melvin L.K.
Eng, Cathy
Hotte, Sebastien J.
Wolff, Robert A.
Alhuraiji, Ahmad
Curigliano, Giuseppe
Almuhanna, Meshari
Ibrahim, Nuhad K.
Coomes, Eric A.
Xie, Conghua
Grothey, Axel
Al‐Shamsi, Humaid O.
Chemaly, Roy F.
Meyers, Brandon M.
Alhazzani, Waleed
Elfiki, Tarek
AuthorAffiliation 7 Division of Infectious Disease, Department of Medicine, University of Toronto Toronto Ontario Canada
5 Medicine, McMaster University Hamilton Ontario Canada
12 Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore Singapore
21 IRCCS, University of Milano Milan Italy
13 Oncology Academic Program, Duke‐NUS Medical School Singapore
4 Department of Health Research Methods, Evidence, and Impact, Medicine, McMaster University Hamilton Ontario Canada
20 European Institute of Oncology Milan Italy
6 Department of Hematology, Kuwait Cancer Control Center Kuwait
23 West Cancer Center, University of Tennessee Memphis Tennessee USA
22 Vanderbilt‐Ingram Cancer Center Nashville Tennessee USA
8 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center Houston Texas USA
1 Medical Oncology Department, Alzahra Hospital Dubai Dubai United Arab Emirates
10 Department of Breast Medical Oncology, The University of Texas
AuthorAffiliation_xml – name: 10 Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center Houston Texas USA
– name: 8 Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center Houston Texas USA
– name: 9 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center Houston Texas USA
– name: 6 Department of Hematology, Kuwait Cancer Control Center Kuwait
– name: 14 Cong Hua's Institute Singapore
– name: 1 Medical Oncology Department, Alzahra Hospital Dubai Dubai United Arab Emirates
– name: 5 Medicine, McMaster University Hamilton Ontario Canada
– name: 20 European Institute of Oncology Milan Italy
– name: 24 Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University Wuhan People's Republic of China
– name: 21 IRCCS, University of Milano Milan Italy
– name: 11 Min‐Sheng General Hospital Taoyuan City Taiwan
– name: 17 Department of Oncology, Schulich School of Medicine, University of Western Ontario London Ontario Canada
– name: 19 Division of Early Drug Development for Innovative Therapy, University of Milan Milan Italy
– name: 23 West Cancer Center, University of Tennessee Memphis Tennessee USA
– name: 12 Divisions of Radiation Oncology and Medical Sciences, National Cancer Center Singapore Singapore
– name: 13 Oncology Academic Program, Duke‐NUS Medical School Singapore
– name: 15 Department of Oncology, Juravinski Cancer Centre, McMaster University Hamilton Ontario Canada
– name: 2 Department of Medicine, University of Sharjah Sharjah United Arab Emirates
– name: 3 Emirates Oncology Society Dubai United Arab Emirates
– name: 4 Department of Health Research Methods, Evidence, and Impact, Medicine, McMaster University Hamilton Ontario Canada
– name: 18 Department of Oncology and Hemato‐Oncology University of Milan Milan Italy
– name: 16 Windsor Regional Cancer Center Windsor Ontario Canada
– name: 22 Vanderbilt‐Ingram Cancer Center Nashville Tennessee USA
– name: 7 Division of Infectious Disease, Department of Medicine, University of Toronto Toronto Ontario Canada
Author_xml – sequence: 1
  givenname: Humaid O.
  orcidid: 0000-0003-3819-0500
  surname: Al‐Shamsi
  fullname: Al‐Shamsi, Humaid O.
  email: Humaid.Al-Shamsi@medportal.ca
  organization: Emirates Oncology Society
– sequence: 2
  givenname: Waleed
  surname: Alhazzani
  fullname: Alhazzani, Waleed
  organization: Medicine, McMaster University
– sequence: 3
  givenname: Ahmad
  surname: Alhuraiji
  fullname: Alhuraiji, Ahmad
  organization: Department of Hematology, Kuwait Cancer Control Center
– sequence: 4
  givenname: Eric A.
  surname: Coomes
  fullname: Coomes, Eric A.
  organization: Division of Infectious Disease, Department of Medicine, University of Toronto
– sequence: 5
  givenname: Roy F.
  surname: Chemaly
  fullname: Chemaly, Roy F.
  organization: Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center
– sequence: 6
  givenname: Meshari
  surname: Almuhanna
  fullname: Almuhanna, Meshari
  organization: Min‐Sheng General Hospital
– sequence: 7
  givenname: Robert A.
  surname: Wolff
  fullname: Wolff, Robert A.
  organization: Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center
– sequence: 8
  givenname: Nuhad K.
  surname: Ibrahim
  fullname: Ibrahim, Nuhad K.
  organization: Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center
– sequence: 9
  givenname: Melvin L.K.
  surname: Chua
  fullname: Chua, Melvin L.K.
  organization: Cong Hua's Institute
– sequence: 10
  givenname: Sebastien J.
  surname: Hotte
  fullname: Hotte, Sebastien J.
  organization: Department of Oncology, Juravinski Cancer Centre, McMaster University
– sequence: 11
  givenname: Brandon M.
  surname: Meyers
  fullname: Meyers, Brandon M.
  organization: Department of Oncology, Juravinski Cancer Centre, McMaster University
– sequence: 12
  givenname: Tarek
  surname: Elfiki
  fullname: Elfiki, Tarek
  organization: Department of Oncology, Schulich School of Medicine, University of Western Ontario
– sequence: 13
  givenname: Giuseppe
  surname: Curigliano
  fullname: Curigliano, Giuseppe
  organization: IRCCS, University of Milano
– sequence: 14
  givenname: Cathy
  surname: Eng
  fullname: Eng, Cathy
  organization: Vanderbilt‐Ingram Cancer Center
– sequence: 15
  givenname: Axel
  surname: Grothey
  fullname: Grothey, Axel
  organization: West Cancer Center, University of Tennessee
– sequence: 16
  givenname: Conghua
  surname: Xie
  fullname: Xie, Conghua
  organization: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32243668$$D View this record in MEDLINE/PubMed
BookMark eNqNUstu1DAUjVARfcAvgJdlkeJ3EiQqjVIoI5VOF4DYWY5zM2OUsYOdDOqOT-AP-De-BE87RZQNrHztex6-9jnM9px3kGXPCD4hkvEX4wq8M773SxvHE4opzjEl7EF2QASvcl7hT3upxiXLCyKq_ewwxs8Yp5LRR9k-o5QzKcuD7McMXQVtRmt0j2bDELw2KzR6lBzQO-30EtbgRuQ7VGtnIKArPdp0EtHZFKxb3gAv_QZ6VPvgnd7YMKWmjaAjIIpJhY7rxcf52c9v30n1PPFdC2trXqKZQ3M3QnBJMRG3An2vGx_SfgPoPPhpeJw97HQf4cluPco-vHn9vn6bXyzO5_XsIjeClTLXhehwqxlmRkijoROMdrwVLceE6EbIkhjgRpCGSiNEUxWSAGlbaXgleSPZUXZ6qztMzRpakyYMuldDsGsdrpXXVt3vOLtSS79RBS1LKUkSON4JBP9lgjiqtY0G0kAO_BQVTdekJSeiTNCnf3r9Nrn7lQR4dQswwccYoFPGjjePlKxtrwhW2xSoeylQ2xSobQoSv_iLf2fxb-buGb7aHq7_l6YWl_UisbFkvwBYsNOW
CitedBy_id crossref_primary_10_2217_fon_2021_0400
crossref_primary_10_37882_2223_2966_2021_01_19
crossref_primary_10_1016_j_medcli_2020_05_028
crossref_primary_10_1155_2023_6659212
crossref_primary_10_1002_onco_13578
crossref_primary_10_1007_s00520_022_07390_y
crossref_primary_10_1007_s00701_021_04723_4
crossref_primary_10_3389_fonc_2022_857076
crossref_primary_10_1016_j_heliyon_2024_e35417
crossref_primary_10_1007_s00520_022_07238_5
crossref_primary_10_7759_cureus_66501
crossref_primary_10_1017_S1460396920001004
crossref_primary_10_1080_08941939_2020_1870180
crossref_primary_10_1590_fm_2022_35605_0
crossref_primary_10_1007_s00268_020_05595_y
crossref_primary_10_1177_20514158211000197
crossref_primary_10_1186_s43045_022_00181_5
crossref_primary_10_5812_archcid_104590
crossref_primary_10_1177_03008916211063939
crossref_primary_10_1136_esmoopen_2020_000810
crossref_primary_10_1007_s13187_023_02321_9
crossref_primary_10_2174_2666796701999201109213143
crossref_primary_10_1186_s40733_020_00064_8
crossref_primary_10_1016_j_lungcan_2021_05_014
crossref_primary_10_2196_23795
crossref_primary_10_3390_ijerph19137926
crossref_primary_10_4274_ejbh_galenos_2022_2022_4_4
crossref_primary_10_1016_j_lanwpc_2021_100226
crossref_primary_10_1080_20479700_2023_2261691
crossref_primary_10_1002_cncr_33453
crossref_primary_10_1038_s41598_024_55886_w
crossref_primary_10_1016_j_cscee_2022_100184
crossref_primary_10_1016_j_medcle_2020_05_021
crossref_primary_10_20492_aeahtd_817933
crossref_primary_10_1007_s13193_023_01797_7
crossref_primary_10_1016_j_molstruc_2022_134135
crossref_primary_10_3389_fmolb_2021_673360
crossref_primary_10_1177_1078155221990101
crossref_primary_10_1016_j_ejon_2021_102030
crossref_primary_10_1002_jso_26143
crossref_primary_10_1002_cam4_6489
crossref_primary_10_3390_medicina58121701
crossref_primary_10_3390_curroncol28040269
crossref_primary_10_3390_cancers13051035
crossref_primary_10_1200_CCI_20_00134
crossref_primary_10_1016_j_heliyon_2022_e08819
crossref_primary_10_1016_j_semerg_2020_11_002
crossref_primary_10_3390_cancers13030371
crossref_primary_10_1016_j_jorep_2025_100552
crossref_primary_10_1038_s41416_022_01909_0
crossref_primary_10_1055_s_0040_1714312
crossref_primary_10_1136_jmedgenet_2020_107418
crossref_primary_10_1007_s42399_020_00592_7
crossref_primary_10_3390_molecules27165303
crossref_primary_10_4018_IJICTHD_313978
crossref_primary_10_3389_fmed_2020_561168
crossref_primary_10_1002_jso_26392
crossref_primary_10_1186_s40814_023_01316_z
crossref_primary_10_3389_fpsyt_2021_679932
crossref_primary_10_3389_fpubh_2022_908756
crossref_primary_10_3389_fonc_2020_00734
crossref_primary_10_1016_j_clcc_2020_07_003
crossref_primary_10_1186_s13027_024_00594_3
crossref_primary_10_4081_oncol_2021_510
crossref_primary_10_1111_jrh_12648
crossref_primary_10_1016_j_amjms_2022_05_017
crossref_primary_10_29121_shodhkosh_v4_i2_2023_2465
crossref_primary_10_1016_j_ejca_2020_05_015
crossref_primary_10_1590_s1678_9946202264039
crossref_primary_10_2139_ssrn_3960706
crossref_primary_10_4103_ajm_ajm_166_20
crossref_primary_10_5812_archcid_107788
crossref_primary_10_1016_j_clbc_2023_04_006
crossref_primary_10_1186_s13048_020_00684_x
crossref_primary_10_2217_fon_2022_0166
crossref_primary_10_1177_08901171241262224
crossref_primary_10_18632_aging_203739
crossref_primary_10_1097_SLA_0000000000005015
crossref_primary_10_1136_jclinpath_2021_207850
crossref_primary_10_1177_01939459221114634
crossref_primary_10_1016_j_wneu_2021_07_082
crossref_primary_10_1634_theoncologist_2020_0516
crossref_primary_10_1016_j_jacr_2020_09_027
crossref_primary_10_1007_s00066_021_01853_7
crossref_primary_10_31033_ijemr_9_2_22
crossref_primary_10_1016_j_critrevonc_2020_103129
crossref_primary_10_1055_s_0041_1725162
crossref_primary_10_1186_s44201_022_00011_8
crossref_primary_10_3390_ijerph192315808
crossref_primary_10_1016_j_jiph_2021_05_005
crossref_primary_10_55010_imcjms_16_016
crossref_primary_10_1002_cam4_5598
crossref_primary_10_2196_34128
crossref_primary_10_35509_01239015_690
crossref_primary_10_1590_0034_7167_2022_0428pt
crossref_primary_10_1007_s13193_020_01082_x
crossref_primary_10_1053_j_seminoncol_2020_12_002
crossref_primary_10_1007_s42399_020_00632_2
crossref_primary_10_1016_j_ejca_2021_02_027
crossref_primary_10_1097_01_REO_0000000000000233
crossref_primary_10_31067_acusaglik_1264256
crossref_primary_10_1007_s10389_022_01767_3
crossref_primary_10_1007_s00520_020_05767_5
crossref_primary_10_1111_bjh_16815
crossref_primary_10_1200_OP_24_00516
crossref_primary_10_1007_s00520_021_06001_6
crossref_primary_10_3390_ijerph182413084
crossref_primary_10_1053_j_seminoncol_2021_07_001
crossref_primary_10_1136_bmjopen_2022_067986
crossref_primary_10_33808_clinexphealthsci_951533
crossref_primary_10_4103_jrcr_jrcr_52_20
crossref_primary_10_1371_journal_pgph_0001534
crossref_primary_10_2139_ssrn_3936503
crossref_primary_10_1111_tbj_13926
crossref_primary_10_1177_1010539520937103
crossref_primary_10_3390_cancers12113266
crossref_primary_10_1016_j_lana_2023_100566
crossref_primary_10_1111_tbj_13920
crossref_primary_10_1177_0963689720968749
crossref_primary_10_3390_healthcare9101401
crossref_primary_10_3389_fpubh_2022_873219
crossref_primary_10_1002_cncr_33113
crossref_primary_10_1016_j_ejca_2020_05_023
crossref_primary_10_1136_ijgc_2021_002784
crossref_primary_10_1136_bmj_n1647
crossref_primary_10_54376_rcmui_v1i1_99
crossref_primary_10_55010_imcjms_17_001
crossref_primary_10_1055_s_0041_1727560
crossref_primary_10_1590_0034_7167_2022_0428
crossref_primary_10_1002_ijc_33601
crossref_primary_10_4048_jbc_2020_23_e56
crossref_primary_10_25259_SNI_440_2023
crossref_primary_10_1634_theoncologist_2020_0442
crossref_primary_10_1186_s12889_022_14972_2
crossref_primary_10_12998_wjcc_v8_i16_3390
crossref_primary_10_1111_aas_13991
crossref_primary_10_1590_s1677_5538_ibju_2020_s125
crossref_primary_10_1136_jclinpath_2021_207425
crossref_primary_10_1016_j_jacr_2021_10_022
crossref_primary_10_1186_s13643_021_01592_x
crossref_primary_10_14271_DMS_21424_EN
crossref_primary_10_1016_j_esr_2025_101656
crossref_primary_10_1007_s12262_020_02452_z
crossref_primary_10_1007_s13304_020_00947_8
crossref_primary_10_16899_jcm_977905
crossref_primary_10_1055_s_0041_1725155
crossref_primary_10_1016_j_seizure_2021_03_029
crossref_primary_10_3390_bs12070211
crossref_primary_10_1038_s41416_021_01555_y
crossref_primary_10_2196_20328
crossref_primary_10_1016_j_oraloncology_2020_104734
crossref_primary_10_1016_j_adro_2021_100754
crossref_primary_10_1007_s00595_022_02610_8
crossref_primary_10_5306_wjco_v11_i12_968
crossref_primary_10_1007_s11912_020_00934_7
crossref_primary_10_1186_s12911_024_02507_1
crossref_primary_10_2147_IDR_S324569
crossref_primary_10_1017_S1460396921000303
crossref_primary_10_1016_j_ccell_2020_09_017
crossref_primary_10_1188_21_CJON_41_47
crossref_primary_10_36106_ijsr_4905785
crossref_primary_10_1002_hed_26366
crossref_primary_10_1111_tid_13363
crossref_primary_10_3390_jcm10040587
crossref_primary_10_1002_cncr_33042
crossref_primary_10_1007_s10585_021_10083_1
crossref_primary_10_1016_j_jgo_2020_09_028
crossref_primary_10_3390_clinpract12060101
crossref_primary_10_25259_SNI_191_2020
crossref_primary_10_1111_dth_13686
crossref_primary_10_1159_000530179
crossref_primary_10_1016_j_adro_2022_100924
crossref_primary_10_2196_30492
crossref_primary_10_3390_ijerph18094761
crossref_primary_10_1007_s10549_021_06468_1
crossref_primary_10_1002_mp_16328
crossref_primary_10_1158_1078_0432_CCR_20_2989
crossref_primary_10_15388_Amed_2021_28_2_9
crossref_primary_10_1634_theoncologist_2020_0451
crossref_primary_10_1200_OP_20_01062
crossref_primary_10_7759_cureus_73313
crossref_primary_10_5812_ijcm_109477
crossref_primary_10_1080_00185868_2021_1942360
crossref_primary_10_1007_s00520_020_05588_6
crossref_primary_10_1002_hsr2_744
crossref_primary_10_1016_j_radonc_2020_04_041
crossref_primary_10_3399_BJGPO_2022_0073
crossref_primary_10_56986_pim_2022_09_001
crossref_primary_10_1186_s12885_020_07544_3
crossref_primary_10_1200_GO_20_00423
crossref_primary_10_2196_24619
crossref_primary_10_3390_ijerph192013187
crossref_primary_10_1111_jonm_13399
crossref_primary_10_3928_01477447_20210618_13
crossref_primary_10_1061__ASCE_LA_1943_4170_0000545
crossref_primary_10_1007_s00520_022_07123_1
crossref_primary_10_1016_j_glohj_2020_11_005
crossref_primary_10_32322_jhsm_1220104
crossref_primary_10_35713_aic_v1_i1_8
crossref_primary_10_3390_curroncol29100529
crossref_primary_10_1634_theoncologist_2020_0360
crossref_primary_10_1016_j_rpor_2020_07_001
crossref_primary_10_3390_ph13070143
crossref_primary_10_3280_mesa2023_127oa17874
crossref_primary_10_1002_hed_26199
crossref_primary_10_1002_cam4_3682
crossref_primary_10_1007_s00520_021_06089_w
crossref_primary_10_1016_j_dsx_2021_05_004
crossref_primary_10_1200_CCI_20_00183
crossref_primary_10_1016_j_jpainsymman_2020_08_037
crossref_primary_10_1186_s42077_020_00110_w
crossref_primary_10_17533_udea_iatreia_312
crossref_primary_10_3390_curroncol29110675
crossref_primary_10_1007_s11136_021_02795_4
crossref_primary_10_1016_j_ienj_2024_101478
crossref_primary_10_1016_j_heliyon_2023_e13432
crossref_primary_10_1016_j_amjsurg_2022_07_015
crossref_primary_10_21320_1818_474X_2020_S1_9_120
crossref_primary_10_1159_000511884
crossref_primary_10_1002_onco_13556
crossref_primary_10_1007_s00432_020_03426_0
crossref_primary_10_1093_ptj_pzaa141
crossref_primary_10_1002_cam4_3692
crossref_primary_10_3322_caac_21635
crossref_primary_10_1111_bjhp_12493
crossref_primary_10_3389_fpubh_2022_755201
crossref_primary_10_1007_s11356_021_15275_6
crossref_primary_10_1556_650_2022_32503
crossref_primary_10_29289_2594539420200084
crossref_primary_10_1007_s00262_023_03524_1
crossref_primary_10_1155_2024_8873127
crossref_primary_10_6061_clinics_2020_e2084
crossref_primary_10_1159_000511993
crossref_primary_10_3389_fsurg_2022_811108
crossref_primary_10_1007_s12609_022_00441_7
crossref_primary_10_1016_j_heliyon_2021_e06658
crossref_primary_10_1371_journal_pone_0275038
crossref_primary_10_3390_cancers13071514
crossref_primary_10_4103_joah_joah_10_21
crossref_primary_10_1186_s12913_024_11769_4
crossref_primary_10_1111_myc_13334
crossref_primary_10_1249_TJX_0000000000000199
crossref_primary_10_3390_jcm13247673
crossref_primary_10_1007_s00520_024_08885_6
crossref_primary_10_3892_mmr_2022_12779
crossref_primary_10_3390_healthcare10050825
crossref_primary_10_7759_cureus_10138
crossref_primary_10_3390_curroncol30050390
crossref_primary_10_1007_s12609_021_00429_9
crossref_primary_10_1002_cam4_3754
crossref_primary_10_1097_CAD_0000000000001040
crossref_primary_10_1007_s12070_020_02218_9
crossref_primary_10_1111_jar_12914
crossref_primary_10_1093_jnci_djaa200
crossref_primary_10_1016_j_semerg_2020_07_007
crossref_primary_10_1017_dmp_2021_294
crossref_primary_10_11622_smedj_2021081
crossref_primary_10_3390_jcm11041022
crossref_primary_10_7759_cureus_23333
crossref_primary_10_3390_jcm10040880
crossref_primary_10_1634_theoncologist_2020_0285
crossref_primary_10_1080_14737140_2021_1837628
crossref_primary_10_1016_j_clindermatol_2021_01_015
crossref_primary_10_3390_curroncol28010026
crossref_primary_10_47093_2218_7332_2020_11_2_62_73
crossref_primary_10_1177_20552076231152163
crossref_primary_10_12688_openreseurope_13841_1
crossref_primary_10_18632_aging_104205
crossref_primary_10_1055_s_0041_1726513
crossref_primary_10_1080_13696998_2020_1833339
crossref_primary_10_3390_curroncol28010034
crossref_primary_10_1136_bmjopen_2021_060038
crossref_primary_10_54061_jphn_1224713
crossref_primary_10_1007_s13369_021_06040_5
crossref_primary_10_2174_2212697X07999201231200429
crossref_primary_10_1016_j_breast_2021_06_006
crossref_primary_10_1016_j_jgo_2020_04_010
crossref_primary_10_1136_spcare_2023_004184
crossref_primary_10_1007_s40487_022_00207_2
crossref_primary_10_1177_1078155220935564
crossref_primary_10_1136_jitc_2020_000984
crossref_primary_10_1007_s00520_021_06205_w
crossref_primary_10_2217_fon_2020_0450
crossref_primary_10_7748_cnp_2023_e1854
crossref_primary_10_1200_EDBK_320691
crossref_primary_10_3389_fpsyt_2022_811083
crossref_primary_10_1007_s12029_020_00557_y
crossref_primary_10_3389_fonc_2020_01279
crossref_primary_10_1016_j_jcbs_2022_03_006
crossref_primary_10_1111_ajco_13724
crossref_primary_10_1200_OP_20_00701
crossref_primary_10_2217_fon_2020_0574
crossref_primary_10_2147_CMAR_S272008
crossref_primary_10_1159_000513180
crossref_primary_10_2217_fon_2023_0200
crossref_primary_10_1007_s10549_025_07617_6
crossref_primary_10_3389_fcvm_2021_634291
crossref_primary_10_3389_fonc_2020_01267
crossref_primary_10_4103_joacp_JOACP_454_20
crossref_primary_10_1001_jamaoncol_2020_2548
crossref_primary_10_1188_21_ONF_131_145
crossref_primary_10_3389_fonc_2022_955377
crossref_primary_10_1210_jendso_bvab059
crossref_primary_10_1016_j_esmoop_2020_100038
crossref_primary_10_1111_dth_13778
crossref_primary_10_3389_fpsyt_2021_557834
crossref_primary_10_3390_ijerph17155403
crossref_primary_10_35460_2546_1621_2021_0018
crossref_primary_10_61186_johe_12_1_4
crossref_primary_10_2147_IJGM_S373191
crossref_primary_10_1016_j_matt_2020_08_026
crossref_primary_10_4143_crt_2021_585
crossref_primary_10_5937_mp75_44652
crossref_primary_10_1097_SLA_0000000000004619
crossref_primary_10_1002_onco_13706
crossref_primary_10_3390_medicina60121924
crossref_primary_10_1080_19427867_2021_1904736
crossref_primary_10_1016_j_jgo_2022_08_003
crossref_primary_10_4103_jisprm_jisprm_10_20
crossref_primary_10_1016_j_clbc_2020_10_012
crossref_primary_10_1136_bcr_2020_237197
crossref_primary_10_1186_s12894_022_01023_6
crossref_primary_10_1007_s10549_021_06362_w
crossref_primary_10_1016_j_ctrv_2020_102068
crossref_primary_10_3390_cancers13235924
crossref_primary_10_21931_RB_2020_05_04_23
crossref_primary_10_1053_j_seminoncol_2022_04_004
crossref_primary_10_1109_ACCESS_2021_3049398
crossref_primary_10_1002_cam4_3612
crossref_primary_10_1002_hpm_3060
crossref_primary_10_1093_oncolo_oyac029
crossref_primary_10_1016_j_csbj_2021_01_005
crossref_primary_10_1016_j_soncn_2020_151090
crossref_primary_10_2196_19691
crossref_primary_10_5694_mja2_51304
crossref_primary_10_1016_j_surg_2022_08_014
crossref_primary_10_3389_fonc_2022_991485
crossref_primary_10_1186_s12885_020_07115_6
crossref_primary_10_1007_s00520_020_05684_7
crossref_primary_10_1002_cam4_3503
crossref_primary_10_1002_onco_13604
crossref_primary_10_51847_XGC5XdfGWO
crossref_primary_10_1093_oncolo_oyab042
crossref_primary_10_1097_CEJ_0000000000000686
crossref_primary_10_3389_fmolb_2021_643004
crossref_primary_10_1038_s41598_021_84780_y
crossref_primary_10_1001_jamaoncol_2022_0752
crossref_primary_10_1080_00981389_2024_2324859
crossref_primary_10_18787_jr_2023_00015
crossref_primary_10_5582_bst_2022_01251
crossref_primary_10_1016_j_heliyon_2023_e15122
crossref_primary_10_3389_fonc_2020_00925
crossref_primary_10_2196_36364
crossref_primary_10_1007_s00520_021_06552_8
crossref_primary_10_1055_s_0040_1722809
crossref_primary_10_1093_trstmh_trab042
crossref_primary_10_1159_000512152
crossref_primary_10_1007_s00520_020_05636_1
crossref_primary_10_1080_21645515_2020_1780846
crossref_primary_10_21675_2357_707X_2022_v13_e_202228ESP1
crossref_primary_10_1093_trstmh_trac015
crossref_primary_10_1111_tbj_13876
crossref_primary_10_3390_ijerph18084122
crossref_primary_10_1001_jamanetworkopen_2024_12050
crossref_primary_10_2196_26799
crossref_primary_10_1016_j_ejca_2021_06_029
crossref_primary_10_1038_s41416_022_01919_y
crossref_primary_10_1080_0284186X_2020_1837392
crossref_primary_10_1080_09593985_2022_2135977
crossref_primary_10_1155_2021_9923518
crossref_primary_10_1007_s42399_020_00425_7
crossref_primary_10_15864_ajabtr_1302
crossref_primary_10_1097_PRS_0000000000010127
crossref_primary_10_1007_s43465_020_00143_1
crossref_primary_10_14710_nmjn_v13i3_54738
crossref_primary_10_3390_medsci11040068
crossref_primary_10_1136_bmjspcare_2021_002946
crossref_primary_10_1136_archdischild_2022_324905
crossref_primary_10_24060_2076_3093_202010_3_233_240
crossref_primary_10_1038_s41598_021_93076_0
crossref_primary_10_1177_10781552211020100
crossref_primary_10_1016_j_diii_2020_04_005
crossref_primary_10_1016_j_seizure_2020_12_001
crossref_primary_10_3389_fmed_2021_646506
crossref_primary_10_20492_aeahtd_1351744
crossref_primary_10_3389_fpsyg_2021_811078
crossref_primary_10_1016_j_clgc_2024_02_009
crossref_primary_10_1007_s11060_020_03523_7
crossref_primary_10_2147_RMHP_S261357
crossref_primary_10_1038_s41598_021_98878_w
crossref_primary_10_1186_s12992_021_00690_8
crossref_primary_10_5306_wjco_v13_i10_835
crossref_primary_10_3390_healthcare12131358
crossref_primary_10_1002_jso_26787
crossref_primary_10_3390_cancers15123115
crossref_primary_10_1007_s13193_021_01478_3
crossref_primary_10_1080_01635581_2020_1797126
crossref_primary_10_1159_000514784
crossref_primary_10_1177_1357633X221122125
crossref_primary_10_3390_ijerph19137753
crossref_primary_10_1007_s00264_020_04736_1
crossref_primary_10_1007_s00520_021_06489_y
crossref_primary_10_21320_1818_474X_2021_S1_9_143
crossref_primary_10_1016_j_phoj_2020_11_001
crossref_primary_10_2147_CMAR_S258121
crossref_primary_10_1080_17538157_2022_2082297
crossref_primary_10_1177_1049732321990360
crossref_primary_10_1200_OP_20_00535
crossref_primary_10_1007_s10549_024_07562_w
crossref_primary_10_1590_fm_2022_35605
crossref_primary_10_1007_s00520_020_05713_5
crossref_primary_10_1007_s10654_022_00912_2
crossref_primary_10_1183_13993003_02672_2020
crossref_primary_10_1016_j_lungcan_2020_12_012
crossref_primary_10_4291_wjgp_v13_i5_157
crossref_primary_10_1007_s00520_020_05966_0
crossref_primary_10_2147_PPA_S263022
crossref_primary_10_31744_einstein_journal_2021AO6254
crossref_primary_10_1182_bloodadvances_2020003883
crossref_primary_10_2147_IJGM_S275775
crossref_primary_10_1002_jso_26452
crossref_primary_10_7717_peerj_13480
crossref_primary_10_1002_acm2_12898
crossref_primary_10_1016_j_clinthera_2024_09_011
crossref_primary_10_1053_j_seminoncol_2021_01_002
crossref_primary_10_1016_j_jcol_2020_06_002
crossref_primary_10_1002_cam4_5184
crossref_primary_10_3390_curroncol31020059
crossref_primary_10_47717_turkjsurg_2021_5069
crossref_primary_10_1016_j_compbiomed_2021_104878
crossref_primary_10_1007_s00464_022_09762_1
crossref_primary_10_3389_fmed_2020_00486
crossref_primary_10_3390_healthcare11040611
crossref_primary_10_1002_jso_26581
crossref_primary_10_1159_000513140
crossref_primary_10_3390_curroncol29030143
crossref_primary_10_1001_jamaoncol_2020_5745
crossref_primary_10_3389_fonc_2021_693002
crossref_primary_10_1007_s10549_020_05877_y
crossref_primary_10_1111_ecc_13265
crossref_primary_10_2147_CMAR_S274525
crossref_primary_10_1016_j_jvs_2021_08_083
crossref_primary_10_3389_fcvm_2020_00145
crossref_primary_10_1017_dmp_2020_188
crossref_primary_10_1186_s13256_022_03745_5
crossref_primary_10_3390_biology9080181
crossref_primary_10_1177_00031348211047205
crossref_primary_10_3390_cancers15164054
crossref_primary_10_1177_20552076241304870
crossref_primary_10_1016_j_jemep_2021_100633
crossref_primary_10_3390_vaccines10122072
crossref_primary_10_21320_1818_474X_2022_1_5_140
crossref_primary_10_1177_10732748211044361
crossref_primary_10_1016_j_jmig_2020_04_023
crossref_primary_10_1016_j_jinf_2020_04_026
crossref_primary_10_3390_curroncol29030153
crossref_primary_10_1007_s13346_021_01067_5
Cites_doi 10.1093/cid/civ272
10.1016/j.clcc.2017.01.009
10.1016/S0140-6736(20)30251-8
10.1186/1471-2334-10-340
10.1001/jama.2020.3972
10.1056/NEJMoa2002032
10.1002/cpt.1390
10.1001/jama.2020.4683
10.1093/ofid/ofy053
10.1093/cid/ciu623
10.1200/JOP.2012.000719
10.2807/1560-7917.ES.2020.25.10.2000180
10.1016/j.bbmt.2018.03.004
10.1093/cid/cis844
10.1016/S0140-6736(20)30567-5
10.1016/S1470-2045(12)70116-X
10.1016/j.ejca.2015.08.016
10.1016/j.lungcan.2004.01.002
10.1016/j.jcv.2011.07.015
10.1111/tbj.12758
10.1093/clinids/22.5.778
10.3390/curroncol13040012
10.1016/S0140-6736(20)30154-9
10.1371/journal.pone.0120827
10.1016/S1470-2045(20)30096-6
10.12688/f1000research.5251.1
10.1056/NEJMoa2001316
10.12968/bjcn.2019.24.10.482
10.1200/EDBK_200141
10.2165/00003495-200767100-00004
10.1046/j.0004-8461.2003.01165.x
10.1097/MLR.0b013e3181792525
10.1186/s40880-019-0368-6
10.1056/NEJMe2001126
10.1111/bjh.14027
ContentType Journal Article
Copyright 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
2020 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
Copyright_xml – notice: 2020 The Authors. published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
– notice: 2020 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1634/theoncologist.2020-0213
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate COVID‐19 and Management of Cancer
EISSN 1549-490X
EndPage e945
ExternalDocumentID PMC7288661
32243668
10_1634_theoncologist_2020_0213
ONCO13306
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: Khalifa Foundation ‐ Abu Dhabi ‐ United Arab Emirates
– fundername: F. Hoffmann‐La Roche
– fundername: F. Hoffmann-La Roche
– fundername: Khalifa Foundation - Abu Dhabi - United Arab Emirates
– fundername: ;
GroupedDBID ---
0R~
123
18M
1OC
24P
2WC
36B
4.4
53G
5VS
AAPXW
AAVAP
AAWTL
AAZKR
ABEJV
ABPTD
ABXVV
ACXQS
ADBBV
ADXAS
AEGXH
AENEX
AJAOE
ALMA_UNASSIGNED_HOLDINGS
AMNDL
AOIJS
BAWUL
BFHJK
CS3
DCZOG
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
F5P
FRP
GROUPED_DOAJ
GX1
H13
HYE
HZ~
IAO
IHR
INH
ITC
LUTES
LYRES
O9-
OK1
P2P
P2W
RAO
RHF
RHI
ROL
ROX
RPM
SUPJJ
SV3
TOX
TR2
UDS
W2D
W8F
WIN
WOHZO
WOQ
WOW
XSB
ZZTAW
AAFWJ
AAYXX
ABGNP
AFPKN
CITATION
OVT
CGR
CUY
CVF
ECM
EIF
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
5PM
ID FETCH-LOGICAL-c5386-a75f0da303c56caef532f4d5d4011ab5681ce4c51b26c55b9761e1dd6c4964b63
IEDL.DBID 24P
ISSN 1083-7159
1549-490X
IngestDate Thu Aug 21 13:56:09 EDT 2025
Fri Jul 11 03:59:01 EDT 2025
Wed Feb 19 02:30:32 EST 2025
Tue Jul 01 01:17:18 EDT 2025
Thu Apr 24 23:01:29 EDT 2025
Wed Jan 22 16:33:47 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords COVID-19
Neoplasm
Pandemic
SARS-CoV-2
Coronavirus
Influenza
Language English
License Attribution-NonCommercial-NoDerivs
http://creativecommons.org/licenses/by-nc-nd/4.0
2020 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5386-a75f0da303c56caef532f4d5d4011ab5681ce4c51b26c55b9761e1dd6c4964b63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Disclosures of potential conflicts of interest may be found at the end of this article.
ORCID 0000-0003-3819-0500
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1634%2Ftheoncologist.2020-0213
PMID 32243668
PQID 2386284158
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7288661
proquest_miscellaneous_2386284158
pubmed_primary_32243668
crossref_citationtrail_10_1634_theoncologist_2020_0213
crossref_primary_10_1634_theoncologist_2020_0213
wiley_primary_10_1634_theoncologist_2020_0213_ONCO13306
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate June 2020
PublicationDateYYYYMMDD 2020-06-01
PublicationDate_xml – month: 06
  year: 2020
  text: June 2020
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
PublicationTitle The oncologist (Dayton, Ohio)
PublicationTitleAlternate Oncologist
PublicationYear 2020
Publisher John Wiley & Sons, Inc
Publisher_xml – name: John Wiley & Sons, Inc
References 2010; 10
2020; 42
2006; 13
2020; 382
2015; 51
2004; 45
2015; 10
2017; 23
2019; 39
2011; 52
2019; 106
2011; 36
2012; 13
2013; 9
2018; 24
2004; 53
2014; 3
2018; 5
2020
2020; 395
2017; 16
2013; 56
2015; 61
2019; 24
2003; 47
2014; 59
2020; 25
2008; 46
2017
2020; 21
2007; 67
2018; 38
2016; 173
1996; 22
Perlman (2021122510434755200_onco13306-bib-0014) 2020; 382
Anderson (2021122510434755200_onco13306-bib-0005) 2020; 395
Ohrmalm (2021122510434755200_onco13306-bib-0057) 2010; 10
Bos (2021122510434755200_onco13306-bib-0050) 2015; 51
Battershill (2021122510434755200_onco13306-bib-0009) 2006; 13
Nishiura (2021122510434755200_onco13306-bib-0032) 2020
U.S. Food & Drug Administration (2021122510434755200_onco13306-bib-0025)
Blaschke (2021122510434755200_onco13306-bib-0064) 2011; 52
Numico (2021122510434755200_onco13306-bib-0046) 2015; 10
The New York Times (2021122510434755200_onco13306-bib-0042)
The Cancer Letter (2021122510434755200_onco13306-bib-0021)
Alpert (2021122510434755200_onco13306-bib-0024) 2019; 106
Busta (2021122510434755200_onco13306-bib-0071) 2017
World Health Organization (2021122510434755200_onco13306-bib-0004)
Feng (2021122510434755200_onco13306-bib-0055) 2019; 39
Yang (2021122510434755200_onco13306-bib-0056) 2020; 42
Onder (2021122510434755200_onco13306-bib-0019) 2020
Lee (2021122510434755200_onco13306-bib-0059) 2007; 67
World Health Organization (2021122510434755200_onco13306-bib-0068)
Tablan (2021122510434755200_onco13306-bib-0036) 2004; 53
Hofheinz (2021122510434755200_onco13306-bib-0038) 2012; 13
Dignani (2021122510434755200_onco13306-bib-0008) 2014; 3
World Health rganization (2021122510434755200_onco13306-bib-0035)
American College of Surgeons (2021122510434755200_onco13306-bib-0051)
Liang (2021122510434755200_onco13306-bib-0007) 2020; 21
Repici (2021122510434755200_onco13306-bib-0029) 2020
Mansfield (2021122510434755200_onco13306-bib-0053) 2017; 23
Ventola (2021122510434755200_onco13306-bib-0028) 2011; 36
Centers for Disease Contro and Prevention (2021122510434755200_onco13306-bib-0037)
EBMT (2021122510434755200_onco13306-bib-0066)
Sirintrapun (2021122510434755200_onco13306-bib-0043) 2018; 38
Willan (2021122510434755200_onco13306-bib-0020) 2020
Li (2021122510434755200_onco13306-bib-0015) 2020; 382
U.S. Food & Drug Administration (2021122510434755200_onco13306-bib-0067)
2021122510434755200_onco13306-bib-0072
2021122510434755200_onco13306-bib-0074
Mukherjee (2021122510434755200_onco13306-bib-0022) 2003; 47
2021122510434755200_onco13306-bib-0070
Centers for Disease Control And Prevention (2021122510434755200_onco13306-bib-0052)
Chemaly (2021122510434755200_onco13306-bib-0061) 2014; 59
2021122510434755200_onco13306-bib-0069
Hirsch (2021122510434755200_onco13306-bib-0060) 2013; 56
ASTRO (2021122510434755200_onco13306-bib-0045)
American College of Surgeons (2021122510434755200_onco13306-bib-0054)
Shereen (2021122510434755200_onco13306-bib-0040) 2019; 24
Stukel (2021122510434755200_onco13306-bib-0047) 2008; 46
2021122510434755200_onco13306-bib-0023
Zou (2021122510434755200_onco13306-bib-0039) 2017; 16
Chan (2021122510434755200_onco13306-bib-0016) 2020; 395
Campbell (2021122510434755200_onco13306-bib-0065) 2015; 61
World Health Organization (2021122510434755200_onco13306-bib-0006)
Steinkuller (2021122510434755200_onco13306-bib-0034) 2018; 5
European Centre for Disease Prevention and Control (2021122510434755200_onco13306-bib-0048)
CBC News (2021122510434755200_onco13306-bib-0031)
Sim (2021122510434755200_onco13306-bib-0058) 2018; 24
Mizumoto (2021122510434755200_onco13306-bib-0033) 2020; 25
Doremalen (2021122510434755200_onco13306-bib-0044)
Adams (2021122510434755200_onco13306-bib-0049) 2020
Whimbey (2021122510434755200_onco13306-bib-0062) 1996; 22
Yu (2021122510434755200_onco13306-bib-0003)
Vox (2021122510434755200_onco13306-bib-0027)
Warr (2021122510434755200_onco13306-bib-0041) 2013; 9
Lu (2021122510434755200_onco13306-bib-0013) 2020; 395
Guan (2021122510434755200_onco13306-bib-0002) 2020
2021122510434755200_onco13306-bib-0010
2021122510434755200_onco13306-bib-0011
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2021122510434755200_onco13306-bib-0017)
The Medical Journal of Australia (2021122510434755200_onco13306-bib-0073)
2021122510434755200_onco13306-bib-0012
Chen (2021122510434755200_onco13306-bib-0030) 2004; 45
U.S. Food & Drug Administration (2021122510434755200_onco13306-bib-0026)
Dignan (2021122510434755200_onco13306-bib-0063) 2016; 173
Worldometer (2021122510434755200_onco13306-bib-0001)
2021122510434755200_onco13306-bib-0018
32399999 - Oncologist. 2020 Aug;25(8):e1251
33030774 - Oncologist. 2020 Dec;25(12):e2024-e2028
References_xml – volume: 13
  start-page: 119
  year: 2006
  end-page: 120
  article-title: Influenza pandemic planning for cancer patients
  publication-title: Curr Oncol
– volume: 5
  year: 2018
  article-title: Outpatient infection prevention: A practical primer
  publication-title: Open Forum Infect Dis
– year: 2020
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N Engl J Med
– volume: 395
  start-page: 514
  year: 2020
  end-page: 523
  article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person‐to‐person transmission: A study of a family cluster
  publication-title: Lancet
– volume: 9
  start-page: e182
  year: 2013
  end-page: 185
  article-title: Baseline blood work before initiation of chemotherapy: What is safe in the real world?
  publication-title: J Oncol Pract
– volume: 106
  start-page: 415
  year: 2019
  end-page: 421
  article-title: Impact of oncology drug shortages on chemotherapy treatment
  publication-title: Clin Pharmacol Ther
– volume: 10
  start-page: 340
  year: 2010
  article-title: Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: A matched comparative study
  publication-title: BMC Infect Dis
– year: 2020
  article-title: Care of haematology patients in a COVID‐19 epidemic
  publication-title: Br J Haematol
– volume: 22
  start-page: 778
  year: 1996
  end-page: 782
  article-title: Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
  publication-title: Clin Infect Dis
– volume: 47
  start-page: 143
  year: 2003
  end-page: 145
  article-title: Hiding in the bunker: Challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak
  publication-title: Australas Radiol
– volume: 67
  start-page: 1411
  year: 2007
  end-page: 1427
  article-title: Viral respiratory tract infections in transplant patients: Epidemiology, recognition and management
  publication-title: Drugs
– volume: 25
  year: 2020
  article-title: Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID‐19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
  publication-title: Euro Surveill
– volume: 13
  start-page: 579
  year: 2012
  end-page: 588
  article-title: Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non‐inferiority, phase 3 trial
  publication-title: Lancet Oncol
– volume: 173
  start-page: 380
  year: 2016
  end-page: 393
  article-title: BCSH/BSBMT/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation
  publication-title: Br J Haematol
– volume: 42
  year: 2020
  article-title: Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID‐19) [in Chinese]
  publication-title: Zhonghua Zhong Liu Za Zhi
– volume: 59
  start-page: S344
  issue: Suppl 5
  year: 2014
  end-page: S351
  article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies
  publication-title: Clin Infect Dis
– volume: 61
  start-page: 192
  year: 2015
  end-page: 202
  article-title: Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant
  publication-title: Clin Infect Dis
– volume: 51
  start-page: 2553
  year: 2015
  end-page: 2561
  article-title: Timing of adjuvant chemotherapy and its relation to survival among patients with stage iii colon cancer
  publication-title: Eur J Cancer
– volume: 10
  year: 2015
  article-title: Hospital admission of cancer patients: Avoidable practice or necessary care?
  publication-title: PLoS One
– volume: 56
  start-page: 258
  year: 2013
  end-page: 266
  article-title: Fourth European Conference on Infections in Leukaemia (ECIL‐4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus
  publication-title: Clin Infect Dis
– volume: 16
  start-page: e123
  year: 2017
  end-page: e139
  article-title: Comparison of 5‐fu‐based and capecitabine‐based neoadjuvant chemoradiotherapy in patients with rectal cancer: A meta‐analysis
  publication-title: Clin Colorectal Cancer
– volume: 36
  start-page: 740
  year: 2011
  end-page: 757
  article-title: The drug shortage crisis in the United States: Causes, impact, and management strategies
  publication-title: P T
– year: 2020
  article-title: Estimation of the asymptomatic ratio of novel coronavirus infections (COVID‐19)
  publication-title: Int J Infect Dis
– volume: 395
  start-page: 931
  year: 2020
  end-page: 934
  article-title: How will country‐based mitigation measures influence the course of the COVID‐19 epidemic?
  publication-title: Lancet
– volume: 38
  start-page: 540
  year: 2018
  end-page: 545
  article-title: Telemedicine in cancer care
  publication-title: Am Soc Clin Oncol Educ Book
– volume: 21
  start-page: 335
  year: 2020
  end-page: 337
  article-title: Cancer patients in SARS‐CoV‐2 infection: A nationwide analysis in China
  publication-title: Lancet Oncol
– volume: 39
  start-page: 22
  year: 2019
  article-title: Current cancer situation in china: Good or bad news from the 2018 global cancer statistics?
  publication-title: Cancer Commun (Lond)
– volume: 382
  start-page: 760
  year: 2020
  end-page: 762
  article-title: Another decade, another coronavirus
  publication-title: N Engl J Med
– year: 2020
– year: 2020
  article-title: Supporting the health care workforce during the COVID‐19 global epidemic
  publication-title: JAMA
– volume: 395
  start-page: 565
  year: 2020
  end-page: 574
  article-title: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding
  publication-title: Lancet
– volume: 52
  start-page: 210
  year: 2011
  end-page: 214
  article-title: Non‐invasive sample collection for respiratory virus testing by multiplex PCR
  publication-title: J Clin Virol
– year: 2020
  article-title: Case‐fatality rate and characteristics of patients dying in relation to COVID‐19 in Italy
  publication-title: JAMA
– volume: 24
  start-page: 1490
  year: 2018
  end-page: 1496
  article-title: Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing
  publication-title: Biol Blood Marrow Transplant
– volume: 45
  start-page: 39
  year: 2004
  end-page: 43
  article-title: Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
  publication-title: Lung Cancer
– volume: 46
  start-page: 991
  year: 2008
  end-page: 997
  article-title: Health impact of hospital restrictions on seriously ill hospitalized patients: Lessons from the Toronto SARS outbreak
  publication-title: Med Care
– volume: 382
  start-page: 1199
  year: 2020
  end-page: 1207
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus‐infected pneumonia
  publication-title: N Engl J Med
– year: 2017
– volume: 3
  start-page: 221
  year: 2014
  article-title: Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study
  publication-title: F1000Res
– volume: 53
  start-page: 1
  year: 2004
  end-page: 36
  article-title: Guidelines for preventing health‐care‐associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
  publication-title: MMWR Recomm Rep
– volume: 24
  start-page: 482
  year: 2019
  end-page: 484
  article-title: Delivering chemotherapy at home: How much do we know?
  publication-title: Br nursing Community Nurs
– volume: 23
  start-page: 444
  year: 2017
  end-page: 451
  article-title: Timing of breast cancer surgery‐how much does it matter?
  publication-title: Breast J
– volume: 61
  start-page: 192
  year: 2015
  ident: 2021122510434755200_onco13306-bib-0065
  article-title: Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/civ272
– ident: 2021122510434755200_onco13306-bib-0010
– volume: 16
  start-page: e123
  year: 2017
  ident: 2021122510434755200_onco13306-bib-0039
  article-title: Comparison of 5-fu-based and capecitabine-based neoadjuvant chemoradiotherapy in patients with rectal cancer: A meta-analysis
  publication-title: Clin Colorectal Cancer
  doi: 10.1016/j.clcc.2017.01.009
– ident: 2021122510434755200_onco13306-bib-0037
– ident: 2021122510434755200_onco13306-bib-0031
– volume-title: Integrating clinical research into epidemic response: The Ebola experience. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Board on Global Health; Committee on Clinical Trials During the 2014–2015 Ebola Outbreak
  year: 2017
  ident: 2021122510434755200_onco13306-bib-0071
– volume: 395
  start-page: 565
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0013
  article-title: Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30251-8
– ident: 2021122510434755200_onco13306-bib-0027
– volume: 10
  start-page: 340
  year: 2010
  ident: 2021122510434755200_onco13306-bib-0057
  article-title: Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: A matched comparative study
  publication-title: BMC Infect Dis
  doi: 10.1186/1471-2334-10-340
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0049
  article-title: Supporting the health care workforce during the COVID-19 global epidemic
  publication-title: JAMA
  doi: 10.1001/jama.2020.3972
– ident: 2021122510434755200_onco13306-bib-0042
– ident: 2021122510434755200_onco13306-bib-0066
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0002
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2002032
– ident: 2021122510434755200_onco13306-bib-0018
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0020
  article-title: Care of haematology patients in a COVID-19 epidemic
  publication-title: Br J Haematol
– ident: 2021122510434755200_onco13306-bib-0052
– volume: 106
  start-page: 415
  year: 2019
  ident: 2021122510434755200_onco13306-bib-0024
  article-title: Impact of oncology drug shortages on chemotherapy treatment
  publication-title: Clin Pharmacol Ther
  doi: 10.1002/cpt.1390
– ident: 2021122510434755200_onco13306-bib-0025
– ident: 2021122510434755200_onco13306-bib-0017
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0019
  article-title: Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
  publication-title: JAMA
  doi: 10.1001/jama.2020.4683
– ident: 2021122510434755200_onco13306-bib-0045
– ident: 2021122510434755200_onco13306-bib-0021
– volume: 5
  year: 2018
  ident: 2021122510434755200_onco13306-bib-0034
  article-title: Outpatient infection prevention: A practical primer
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofy053
– volume: 59
  start-page: S344
  issue: Suppl 5
  year: 2014
  ident: 2021122510434755200_onco13306-bib-0061
  article-title: Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciu623
– volume: 9
  start-page: e182
  year: 2013
  ident: 2021122510434755200_onco13306-bib-0041
  article-title: Baseline blood work before initiation of chemotherapy: What is safe in the real world?
  publication-title: J Oncol Pract
  doi: 10.1200/JOP.2012.000719
– volume: 25
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0033
  article-title: Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2020.25.10.2000180
– volume: 24
  start-page: 1490
  year: 2018
  ident: 2021122510434755200_onco13306-bib-0058
  article-title: Viral respiratory tract infections in allogeneic hematopoietic stem cell transplantation recipients in the era of molecular testing
  publication-title: Biol Blood Marrow Transplant
  doi: 10.1016/j.bbmt.2018.03.004
– volume: 56
  start-page: 258
  year: 2013
  ident: 2021122510434755200_onco13306-bib-0060
  article-title: Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis844
– ident: 2021122510434755200_onco13306-bib-0069
– ident: 2021122510434755200_onco13306-bib-0004
– volume: 395
  start-page: 931
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0005
  article-title: How will country-based mitigation measures influence the course of the COVID-19 epidemic?
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30567-5
– ident: 2021122510434755200_onco13306-bib-0072
– volume: 13
  start-page: 579
  year: 2012
  ident: 2021122510434755200_onco13306-bib-0038
  article-title: Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: A randomised, multicentre, non-inferiority, phase 3 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(12)70116-X
– ident: 2021122510434755200_onco13306-bib-0003
– ident: 2021122510434755200_onco13306-bib-0023
– volume: 51
  start-page: 2553
  year: 2015
  ident: 2021122510434755200_onco13306-bib-0050
  article-title: Timing of adjuvant chemotherapy and its relation to survival among patients with stage iii colon cancer
  publication-title: Eur J Cancer
  doi: 10.1016/j.ejca.2015.08.016
– volume: 45
  start-page: 39
  year: 2004
  ident: 2021122510434755200_onco13306-bib-0030
  article-title: Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms
  publication-title: Lung Cancer
  doi: 10.1016/j.lungcan.2004.01.002
– volume: 52
  start-page: 210
  year: 2011
  ident: 2021122510434755200_onco13306-bib-0064
  article-title: Non-invasive sample collection for respiratory virus testing by multiplex PCR
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2011.07.015
– ident: 2021122510434755200_onco13306-bib-0001
– ident: 2021122510434755200_onco13306-bib-0073
– volume: 23
  start-page: 444
  year: 2017
  ident: 2021122510434755200_onco13306-bib-0053
  article-title: Timing of breast cancer surgery-how much does it matter?
  publication-title: Breast J
  doi: 10.1111/tbj.12758
– ident: 2021122510434755200_onco13306-bib-0012
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0029
– ident: 2021122510434755200_onco13306-bib-0048
– ident: 2021122510434755200_onco13306-bib-0006
– volume: 22
  start-page: 778
  year: 1996
  ident: 2021122510434755200_onco13306-bib-0062
  article-title: Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
  publication-title: Clin Infect Dis
  doi: 10.1093/clinids/22.5.778
– ident: 2021122510434755200_onco13306-bib-0044
– volume: 13
  start-page: 119
  year: 2006
  ident: 2021122510434755200_onco13306-bib-0009
  article-title: Influenza pandemic planning for cancer patients
  publication-title: Curr Oncol
  doi: 10.3390/curroncol13040012
– volume: 395
  start-page: 514
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0016
  article-title: A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30154-9
– volume: 10
  year: 2015
  ident: 2021122510434755200_onco13306-bib-0046
  article-title: Hospital admission of cancer patients: Avoidable practice or necessary care?
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0120827
– volume: 21
  start-page: 335
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0007
  article-title: Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(20)30096-6
– volume: 3
  start-page: 221
  year: 2014
  ident: 2021122510434755200_onco13306-bib-0008
  article-title: Pandemic 2009 influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study
  publication-title: F1000Res
  doi: 10.12688/f1000research.5251.1
– volume: 382
  start-page: 1199
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0015
  article-title: Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2001316
– volume: 24
  start-page: 482
  year: 2019
  ident: 2021122510434755200_onco13306-bib-0040
  article-title: Delivering chemotherapy at home: How much do we know?
  publication-title: Br nursing Community Nurs
  doi: 10.12968/bjcn.2019.24.10.482
– ident: 2021122510434755200_onco13306-bib-0054
– ident: 2021122510434755200_onco13306-bib-0026
– ident: 2021122510434755200_onco13306-bib-0067
– ident: 2021122510434755200_onco13306-bib-0011
– year: 2020
  ident: 2021122510434755200_onco13306-bib-0032
  article-title: Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
  publication-title: Int J Infect Dis
– volume: 36
  start-page: 740
  year: 2011
  ident: 2021122510434755200_onco13306-bib-0028
  article-title: The drug shortage crisis in the United States: Causes, impact, and management strategies
  publication-title: P T
– volume: 53
  start-page: 1
  year: 2004
  ident: 2021122510434755200_onco13306-bib-0036
  article-title: Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
  publication-title: MMWR Recomm Rep
– ident: 2021122510434755200_onco13306-bib-0068
– volume: 38
  start-page: 540
  year: 2018
  ident: 2021122510434755200_onco13306-bib-0043
  article-title: Telemedicine in cancer care
  publication-title: Am Soc Clin Oncol Educ Book
  doi: 10.1200/EDBK_200141
– ident: 2021122510434755200_onco13306-bib-0074
– volume: 67
  start-page: 1411
  year: 2007
  ident: 2021122510434755200_onco13306-bib-0059
  article-title: Viral respiratory tract infections in transplant patients: Epidemiology, recognition and management
  publication-title: Drugs
  doi: 10.2165/00003495-200767100-00004
– volume: 47
  start-page: 143
  year: 2003
  ident: 2021122510434755200_onco13306-bib-0022
  article-title: Hiding in the bunker: Challenges for a radiation oncology department operating in the severe acute respiratory syndrome outbreak
  publication-title: Australas Radiol
  doi: 10.1046/j.0004-8461.2003.01165.x
– ident: 2021122510434755200_onco13306-bib-0070
– volume: 46
  start-page: 991
  year: 2008
  ident: 2021122510434755200_onco13306-bib-0047
  article-title: Health impact of hospital restrictions on seriously ill hospitalized patients: Lessons from the Toronto SARS outbreak
  publication-title: Med Care
  doi: 10.1097/MLR.0b013e3181792525
– ident: 2021122510434755200_onco13306-bib-0051
– volume: 39
  start-page: 22
  year: 2019
  ident: 2021122510434755200_onco13306-bib-0055
  article-title: Current cancer situation in china: Good or bad news from the 2018 global cancer statistics?
  publication-title: Cancer Commun (Lond)
  doi: 10.1186/s40880-019-0368-6
– ident: 2021122510434755200_onco13306-bib-0035
– volume: 382
  start-page: 760
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0014
  article-title: Another decade, another coronavirus
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe2001126
– volume: 173
  start-page: 380
  year: 2016
  ident: 2021122510434755200_onco13306-bib-0063
  article-title: BCSH/BSBMT/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation
  publication-title: Br J Haematol
  doi: 10.1111/bjh.14027
– volume: 42
  year: 2020
  ident: 2021122510434755200_onco13306-bib-0056
  article-title: Diagnostic and therapeutic strategies of lung cancer patients during the outbreak of 2019 novel coronavirus disease (COVID-19) [in Chinese]
  publication-title: Zhonghua Zhong Liu Za Zhi
– reference: 33030774 - Oncologist. 2020 Dec;25(12):e2024-e2028
– reference: 32399999 - Oncologist. 2020 Aug;25(8):e1251
SSID ssj0015932
Score 2.7001932
SecondaryResourceType review_article
Snippet The outbreak of coronavirus disease 2019 (COVID‐19) has rapidly spread globally since being identified as a public health emergency of major international...
The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread globally since being identified as a public health emergency of major international...
Cancer patients have an increased risk of contracting COVID‐19. This article addresses the challenges associated with managing cancer patients during the...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e936
SubjectTerms Betacoronavirus - isolation & purification
Betacoronavirus - pathogenicity
Coronavirus
Coronavirus Infections - epidemiology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
Coronavirus Infections - virology
COVID-19
Global Health and Cancer
Hand Hygiene - organization & administration
Hand Hygiene - trends
Humans
Infection Control - organization & administration
Infection Control - trends
Influenza
International Cooperation
Intersectoral Collaboration
Medical Oncology - economics
Medical Oncology - organization & administration
Medical Oncology - standards
Medical Oncology - trends
Neoplasm
Neoplasms - therapy
Pandemic
Pandemics - prevention & control
Patient Care - economics
Patient Care - standards
Patient Care - trends
Patient Education as Topic
Pneumonia, Viral - epidemiology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
Pneumonia, Viral - virology
Resource Allocation - economics
Resource Allocation - organization & administration
Resource Allocation - standards
Resource Allocation - trends
SARS-CoV-2
Telemedicine - economics
Telemedicine - organization & administration
Telemedicine - standards
Telemedicine - trends
World Health Organization
Title A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group
URI https://onlinelibrary.wiley.com/doi/abs/10.1634%2Ftheoncologist.2020-0213
https://www.ncbi.nlm.nih.gov/pubmed/32243668
https://www.proquest.com/docview/2386284158
https://pubmed.ncbi.nlm.nih.gov/PMC7288661
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBZpAqWX0jZ9bPpAhR6Sg6llPdbubXEa0kJ2c0jC3oxeJoFgl83unvsT8g_63_pLOiM5Tk0oDbkYjDTCeGY0T30i5BMXJnO1ZgnT3ibC5SrJmXaJTrHqlxuRGcx3HE3V4an4PpfzDlIIz8JEfIg-4YaaEfZrVHBt4i0kigtgIh70awKyM_wPCPQgDAJ7xR-RLTxoi919mTjuCwqy4LHwmfNkDG9dqxcs9fkfCw0N1R3v824T5d_ObbBOB8_I086tpJMoB8_Jhm9ekMdHXeF8m_ya0IhMZHFWhyNOly2Fz6K3LTC0rWmJcrCgxxFw9Yruh4OMYeK0XftLWiLogV5fLFYwGOs7FAx8QXfL2dm3_d8_r1mxB_RNaLz_QicNHeQdaXkre2tPQ_brJTk9-HpSHibd3QyJhS1SJXos69RpMIBWKqt9LXlWCycdxGtMG4Q1s15YyUymrJQGvB7mmXPKikIJo_grstm0jX9DKOdKOFWMtUm9MKwufG6tgAW4SWvp_IioG0ZUtgMux_szLisMYICD1YCDFXKwQg6OSNoT_ojYHf8n-XjD6Qr0DIsnuvHt6qoC10aBKWcyH5HXkfP9orApCq4UjIwHMtFPQAzv4UhzcR6wvEEfcnCRgDJIz32_s5pNyxnjEO_tPJjyLXkShR1TSu_I5nKx8u_Bw1qaD0F34Hkym_8B4eMnfw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSNBLxbMsFDASBzhExOvHJr2tUqotdHd7aFFvll8Rlaqk2u7umZ_Qf8B_45cw46QpUYVAHCN7nCgz43n6MyHvuLBDXxqWMBNcInymkowZn5gUq36ZFUOL-Y7pTE1OxOdTedr2P-FZmAYfoku4oWbE_RoVHBPSUcsVF8BFPOlXRWhn-CEQ6UEcBAaL3yX3hIL3IMqzOOoqCjLnTeUz48kIntpeL1jq4x8W6luqW-7n7S7K373baJ72H5Kt1q-k40YQHpE7oXpM7k_byvkT8mNMG2gih7NaIHG6rCl8Fr3pgaF1SQsUhAU9ahBXL-lePMkYJ87qdTinBaIemPXZYgWDTYGHgoXP6fti_vVg7-f3K5Z_APoqdt7v0nFFe4lHWtwI3zrQmP56Sk72Px0Xk6S9nCFxsEeqxIxkmXoDFtBJ5UwoJR-WwksPARszFnHNXBBOMjtUTkoLbg8LzHvlRK6EVfwZ2ajqKjwnlHMlvMpHxqZBWFbmIXNOwALcpqX0YUDUNSO0a5HL8QKNc40RDHBQ9ziokYMaOTggaUd40YB3_J3k7TWnNSgaVk9MFerVpQbfRoEtZzIbkO2G892isCsKrhSMjHoy0U1AEO_-SHX2LYJ5g0Jk4CMBZZSef_1OPZ8Vc8Yh4Hvx35RvyIPJ8fRQHx7Mvrwkm43gY35ph2wsF6vwCtytpX0d9egXx3kpzw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELagSBUXxJvlaSQOcIiI48cm3FZZVi3Q3T1Q1FvkV0SlKqm2u3vuT-g_4L_xS5ix05SoQiCOkT2WlZnxPP2ZkDdcmMzVmiVMe5sIl6skZ9olOsWqX25EZjDfcTBXe4fi05E86iCF8C5MxIfoE26oGeG8RgU_dXVQcsUFMBEv-jUB2Rn-BwR6EAaBveI3yS0s_WF3VyaWfUFBFjwWPnOejOGra_WCpd7_YaGhobrmfV5vovzduQ3WaXaX3OncSjqJcnCP3PDNfbJ70BXOH5AfExqRiSzO6nDE6bqlsC161QJD25qWKAcruoyAq2d0Gi4yhonzdutPaImgB3p7vNrAYKzvUDDwBX1bLr7tT3-eX7DiHdA3ofH-A500dJB3pOWV7G09Ddmvh-Rw9vFruZd0bzMkFo5IleixrFOnwQBaqaz2teRZLZx0EK8xbRDWzHphJTOZslIa8HqYZ84pKwoljOKPyE7TNv4JoZwr4VQx1ib1wrC68Lm1AhbgJq2l8yOiLhlR2Q64HN_POKkwgAEOVgMOVsjBCjk4ImlPeBqxO_5O8vqS0xXoGRZPdOPbzVkFro0CU85kPiKPI-f7ReFQFFwpGBkPZKKfgBjew5Hm-HvA8gZ9yMFFAsogPf-6z2oxLxeMQ7z39L8pX5Hd5XRWfdmff35Gbke5x-zSc7KzXm38C3C21uZlUKNf7zspAQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Practical+Approach+to+the+Management+of+Cancer+Patients+During+the+Novel+Coronavirus+Disease+2019+%28COVID-19%29+Pandemic%3A+An+International+Collaborative+Group&rft.jtitle=The+oncologist+%28Dayton%2C+Ohio%29&rft.au=Al-Shamsi%2C+Humaid+O&rft.au=Alhazzani%2C+Waleed&rft.au=Alhuraiji%2C+Ahmad&rft.au=Coomes%2C+Eric+A&rft.date=2020-06-01&rft.issn=1549-490X&rft.eissn=1549-490X&rft.volume=25&rft.issue=6&rft.spage=e936&rft_id=info:doi/10.1634%2Ftheoncologist.2020-0213&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1083-7159&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1083-7159&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1083-7159&client=summon